Unicycive Therapeutics, Inc. (UNCY)
NASDAQ · Manufacturing · Pharmaceutical preparations
UNCY price, last 12 months
Key stats
- Previous close
- $3.57
- Open
- $3.56
- Day range
- $3.42 – $3.65
- 52-week range
- $3.33 – $8.74
- Volume
- 886.1K
- Avg volume (20 days)
- 1.1M
- Market cap
- $98.9M
Performance
Technicals and fundamentals
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $98.9M